AKT3 and breast cancer: In this investigation, AKT3-derived hsa_circ_0000199 was found to specifically over-express in TNBC (Figure 1), and its high expression was associated with clinical symptoms of TNBC patients, rather than the whole BC population (Tables 1, 2).